Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-25 @ 7:01 PM
Study NCT ID:
NCT05136404
Status:
COMPLETED
Last Update Posted:
2025-03-17
First Post:
2021-11-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Relative Bioavailability Study of Selpercatinib (LY3527723) in Healthy Participants
Sponsor:
Loxo Oncology, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-03
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-14
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-25
First Submit QC Date:
None
Study First Post Date:
2021-11-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-27
Results First Submit QC Date:
None
Results First Post Date:
2025-03-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-27
Last Update Post Date:
2025-03-17
Last Update Post Date Type:
ACTUAL